C. Gaujoux-viala, L. Gossec, A. Cantagrel, M. Dougados, B. Fautrel et al., Recommandations de la Soci??t?? fran??aise de rhumatologie pour la prise en charge de la polyarthrite rhumato??de, Revue du Rhumatisme, vol.81, issue.4, p.30312, 2014.
DOI : 10.1016/j.rhum.2014.04.009

R. Haynes, D. Taylor, and D. Sackett, Compliance in health care, p.115, 1979.

E. Sabaté and W. Health-organization, Adherence to long-term therapies: evidence for action. Geneva: World Health Organization, 2003.

A. Lamouroux, A. Magnan, and D. Vervloet, Compliance, observance ou adh??sion th??rapeutique : de quoi parlons-nous ?, Revue des Maladies Respiratoires, vol.22, issue.1, p.314, 2005.
DOI : 10.1016/S0761-8425(05)85433-6

J. Cramer, A. Roy, A. Burrell, C. Fairchild, M. Fuldeore et al., Medication Compliance and Persistence: Terminology and Definitions, Value in Health, vol.11, issue.1, p.447, 2008.
DOI : 10.1111/j.1524-4733.2007.00213.x

T. Koncz, M. Pentek, V. Brodszky, K. Ersek, E. Orlewska et al., Adherence to biologic DMARD therapies in rheumatoid arthritis, Expert Opinion on Biological Therapy, vol.33, issue.2, p.136778, 2010.
DOI : 10.1111/j.1524-4733.2006.00139.x

I. Contreras-yáñez, D. León, S. Cabiedes, J. Gabayet, M. Pascual-ramos et al., Inadequate Therapy Behavior Is Associated to Disease Flares in Patients With Rheumatoid Arthritis Who Have Achieved Remission With Disease-Modifying Antirheumatic Drugs, The American Journal of the Medical Sciences, vol.340, issue.4, p.28290, 2010.
DOI : 10.1097/MAJ.0b013e3181e8bcb0

J. Bluett, C. Morgan, L. Thurston, D. Plant, K. Hyrich et al., Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort, Rheumatology, vol.54, issue.3, p.4949, 2015.
DOI : 10.1093/rheumatology/keu358

L. Osterberg and T. Blaschke, Adherence to Medication, New England Journal of Medicine, vol.353, issue.5, p.48797, 2005.
DOI : 10.1056/NEJMra050100

R. Hansen, M. Kim, L. Song, W. Tu, J. Wu et al., Adherence: Comparison of Methods to Assess Medication Adherence and Classify Nonadherence, Annals of Pharmacotherapy, vol.9, issue.3, p.41322, 2009.
DOI : 10.1345/aph.1L496

A. Lehmann, P. Aslani, R. Ahmed, J. Celio, A. Gauchet et al., Assessing medication adherence: options to consider, International Journal of Clinical Pharmacy, vol.22, issue.2, p.5569, 2014.
DOI : 10.1007/s11096-013-9865-x

S. Garfield, S. Clifford, L. Eliasson, N. Barber, and A. Willson, Suitability of measures of self-reported medication adherence for routine clinical use: A systematic review, BMC Medical Research Methodology, vol.28, issue.1, p.149, 2011.
DOI : 10.1200/JCO.2009.26.3087

D. Morisky, L. Green, and D. Levine, Concurrent and Predictive Validity of a Self-reported Measure of Medication Adherence, Medical Care, vol.24, issue.1, 1986.
DOI : 10.1097/00005650-198601000-00007

D. Morisky, A. Ang, M. Krousel-wood, and H. Ward, Predictive Validity of a Medication Adherence Measure in an Outpatient Setting, The Journal of Clinical Hypertension, vol.17, issue.3, p.34854, 2008.
DOI : 10.1056/NEJMcp041698

X. Girerd, O. Hanon, K. Anagnostopoulo, C. Ciupek, J. Mourad et al., Evaluation de l'observance du traitement antihypertenseur par un questionnaire : mise au point et utilisation dans un service spécialisé, Presse Med. juin, vol.30, issue.21, p.10448, 2011.

B. Van-den-bemt, H. Zwikker, and C. Van-den-ende, Medication adherence in patients with rheumatoid arthritis: a critical appraisal of the existing literature, Expert Review of Clinical Immunology, vol.8, issue.4, p.33751, 2012.
DOI : 10.1586/eci.12.23

E. De-klerk, D. Van-der-heijde, R. Landewé, H. Van-der-tempel, and S. Van-der-linden, The compliance-questionnaire-rheumatology compared with electronic medication event monitoring: a validation study, J Rheumatol, vol.30, issue.11, p.246975, 2003.

A. De-thurah, M. Nørgaard, I. Harder, and K. Stengaard-pedersen, Compliance with methotrexate treatment in patients with rheumatoid arthritis: influence of patients??? beliefs about the medicine. A prospective cohort study, Rheumatology International, vol.50, issue.11, p.14418, 2010.
DOI : 10.1007/s00296-009-1160-8

E. Vangeli, S. Bakhshi, A. Baker, A. Fisher, D. Bucknor et al., A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases, Advances in Therapy, vol.40, issue.3, p.9831028, 2015.
DOI : 10.1007/s12325-015-0256-7

V. Rauscher, M. Englbrecht, D. Van-der-heijde, G. Schett, and A. Hueber, High Degree of Nonadherence to Disease-modifying Antirheumatic Drugs in Patients with Rheumatoid Arthritis, The Journal of Rheumatology, vol.42, issue.3, p.38690, 2015.
DOI : 10.3899/jrheum.140982

S. Achaval, . De, and M. Suarez-almazor, Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus, International Journal of Clinical Rheumatology, vol.5, issue.3, p.31326, 2010.
DOI : 10.2217/ijr.10.15

M. Blum, K. D. Doshi, and J. , Measurement and Rates of Persistence With and Adherence to Biologics for Rheumatoid Arthritis: A Systematic Review, Clinical Therapeutics, vol.33, issue.7, p.90113, 2011.
DOI : 10.1016/j.clinthera.2011.06.001

J. Tkacz, L. Ellis, S. Bolge, R. Meyer, B. Brady et al., Utilization and Adherence Patterns of Subcutaneously Administered Anti???Tumor Necrosis Factor Treatment Among Rheumatoid Arthritis Patients, Clinical Therapeutics, vol.36, issue.5, p.73747, 2014.
DOI : 10.1016/j.clinthera.2014.02.019

L. Kristensen, T. Saxne, J. Nilsson, and P. Geborek, Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden, Arthritis Research & Therapy, vol.8, issue.6, p.174, 2006.
DOI : 10.1186/ar2084

C. Grijalva, C. Chung, P. Arbogast, C. Stein, M. Jr et al., Assessment of Adherence to and Persistence on Disease-Modifying Antirheumatic Drugs (DMARDs) in Patients With Rheumatoid Arthritis, Medical Care, vol.45, issue.Suppl 2, 2007.
DOI : 10.1097/MLR.0b013e318041384c

S. Karve, M. Cleves, M. Helm, T. Hudson, D. West et al., Good and poor adherence: optimal cut-point for adherence measures using administrative claims data, Current Medical Research and Opinion, vol.25, issue.9, 2009.
DOI : 10.1185/03007990903126833

N. Barber, Patients' problems with new medication for chronic conditions, Quality and Safety in Health Care, vol.13, issue.3, p.1725, 2004.
DOI : 10.1136/qshc.2003.005926

A. Garcia-gonzalez, M. Richardson, G. Popa-lisseanu, M. Cox, V. Kallen et al., Treatment adherence in patients with rheumatoid arthritis and systemic lupus erythematosus, Clinical Rheumatology, vol.12, issue.6, p.8839, 2008.
DOI : 10.1007/s10067-007-0816-6

B. Van-den, . Bjf, H. Van-den, . Fhj, B. Benraad et al., Adherence Rates and Associations with Nonadherence in Patients with Rheumatoid Arthritis Using Disease Modifying Antirheumatic Drugs, The Journal of Rheumatology, vol.36, issue.10, p.216470, 2009.
DOI : 10.3899/jrheum.081204

F. Viller, F. Guillemin, S. Briançon, T. Moum, T. Suurmeijer et al., Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study, J Rheumatol. oct, vol.26, issue.10, p.211422, 1999.

R. Neame, Beliefs about medications: a questionnaire survey of people with rheumatoid arthritis, Rheumatology, vol.44, issue.6, p.7627, 2005.
DOI : 10.1093/rheumatology/keh587

R. Tuncay, E. Eksioglu, B. Cakir, E. Gurcay, and A. Cakci, Factors affecting drug treatment compliance in patients with rheumatoid arthritis, Rheumatology International, vol.24, issue.8, p.7436, 2007.
DOI : 10.1007/s00296-006-0299-9

D. Meichenbaum and D. Turk, Facilitating treatment adherence, 1987.
DOI : 10.1007/978-1-4684-5359-1

M. Bonafede, B. Johnson, D. Tang, N. Shah, D. Harrison et al., Etanercept-Methotrexate Combination Therapy Initiators Have Greater Adherence and Persistence Than Triple Therapy Initiators With Rheumatoid Arthritis, Arthritis Care & Research, vol.12, issue.12, p.165663, 2015.
DOI : 10.1002/acr.22638

C. Harley, J. Frytak, and N. Tandon, Treatment compliance and dosage administration among rheumatoid arthritis patients receiving infliximab, etanercept, or methotrexate

P. Voulgari, Y. Alamanos, S. Nikas, D. Bougias, T. Temekonidis et al., Infliximab therapy in established rheumatoid arthritis: An observational study, The American Journal of Medicine, vol.118, issue.5, p.51520, 2005.
DOI : 10.1016/j.amjmed.2005.01.029

A. Betegnie, Adhésion médicamenteuse et représentations des patients atteints de rhumatisme inflammatoire chronique sous biothérapie, 2013.

S. Curkendall, V. Patel, M. Gleeson, R. Campbell, M. Zagari et al., Compliance with biologic therapies for rheumatoid arthritis: Do patient out-of-pocket payments matter?, Arthritis & Rheumatism, vol.354, issue.10, p.151926, 2008.
DOI : 10.1002/art.24114

B. Borah, X. Huang, V. Zarotsky, and D. Globe, Trends in RA patients??? adherence to subcutaneous anti-TNF therapies and costs, Current Medical Research and Opinion, vol.25, issue.6, p.136577, 2009.
DOI : 10.1185/03007990902896386

D. Esposti, L. Sangiorgi, D. Perrone, V. Radice, S. Clementi et al., Adherence and resource use among patients treated with biologic drugs: findings from BEETLE study, ClinicoEconomics and Outcomes Research, vol.401, 2014.
DOI : 10.2147/CEOR.S66338

P. Ho, C. Bryson, and J. Rumsfeld, Medication Adherence: Its Importance in Cardiovascular Outcomes, Circulation, vol.119, issue.23, p.302835, 2009.
DOI : 10.1161/CIRCULATIONAHA.108.768986

D. Cuyper, E. , D. Gucht, V. Maes, S. et al., Determinants of methotrexate adherence in rheumatoid arthritis patients, Clinical Rheumatology, vol.39, issue.3, pp.10067-10083, 2016.
DOI : 10.1007/s10067-016-3182-4

M. Gadallah, D. Boulos, A. Gebrel, S. Dewedar, and D. Morisky, Assessment of Rheumatoid Arthritis Patients? Adherence to Treatment, Am J Med Sci. févr, vol.349, issue.2, p.1516, 2015.

A. Zink, Treatment continuation in patients receiving biological agents or conventional DMARD therapy, Annals of the Rheumatic Diseases, vol.64, issue.9, p.12749, 2005.
DOI : 10.1136/ard.2004.031476

J. Hill, H. Bird, and S. Johnson, Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial, Ann Rheum Dis, vol.60, issue.9, p.86975, 2001.

B. Van-den-bemt, A. Den-broeder, F. Van-den-hoogen, B. Benraad, Y. Hekster et al., Making the rheumatologist aware of patients' non-adherence does not improve medication adherence in patients with rheumatoid arthritis, Scandinavian Journal of Rheumatology, vol.54, issue.1, p.1926, 2011.
DOI : 10.1186/1471-2296-6-20

C. Morgan, J. Mcbeth, L. Cordingley, K. Watson, K. Hyrich et al., The influence of behavioural and psychological factors on medication adherence over time in rheumatoid arthritis patients: a study in the biologics era, Rheumatology, vol.54, issue.10, p.178091, 2015.
DOI : 10.1093/rheumatology/kev105

K. Kumar, K. Raza, P. Nightingale, R. Horne, S. Chapman et al., Determinants of adherence to disease modifying anti-rheumatic drugs in White British and South Asian patients with rheumatoid arthritis: a cross sectional study, BMC Musculoskeletal Disorders, vol.21, issue.17, p.396
DOI : 10.12968/bjon.2012.21.17.1015

G. Treharne, A. Lyons, and G. Kitas, Medication adherence in rheumatoid arthritis: effects of psychosocial factors, Psychology, Health & Medicine, vol.26, issue.3, p.33749, 2004.
DOI : 10.1007/BF00846695

C. Carter, A. Changolkar, S. Mckenzie, and R. , Adalimumab, etanercept, and infliximab utilization patterns and drug costs among rheumatoid arthritis patients, Journal of Medical Economics, vol.15, issue.2, p.3329, 2012.
DOI : 10.3111/13696998.2011.649325

D. Morisky, L. Green, and D. Levine, Concurrent and predictive validity of a self-reported measure of medication adherence. Medical care, pp.67-74, 1986.

X. Girerd, O. Hanon, and K. Anagnostopoulos, Evaluation de l'observance du traitement antihypertenseur par un questionnaire : mise au point et utilisation dans un service spécialisé